Nektar Therapeutics (NKTR) Work In Process (2011 - 2024)

Nektar Therapeutics' Work In Process history runs 12 years deep, the most recent figure standing at $10.6 million for Q2 2024.

• In Q2 2024, Work In Process changed N/A year-over-year to $10.6 million; the TTM figure through Jun 2024 stood at $10.6 million (changed N/A YoY), while the FY2023 annual figure was $12.9 million, up 19.83% from the prior year.
• Work In Process for Q2 2024 stood at $10.6 million, up from $10.0 million in the prior quarter.
• The five-year high for Work In Process was $12.9 million in Q4 2023, with the low at $10.0 million in Q1 2024.
• The 3-year median for Work In Process is $10.7 million (2022), against an average of $11.3 million.
• Peak annual rise in Work In Process reached 19.83% in 2023, while the deepest fall reached 19.83% in 2023.
• Nektar Therapeutics' Work In Process stood at $10.7 million in 2022, then climbed by 19.83% to $12.9 million in 2023, then declined by 17.78% to $10.6 million in 2024.
• Business Quant data shows NKTR's Work In Process at $10.6 million in Q2 2024, $10.0 million in Q1 2024, and $12.9 million in Q4 2023.